BR112022018853A2 - Kit de diagnóstico de nanopoços para diagnóstico de substâncias de doenças cardiovasculares no sangue - Google Patents

Kit de diagnóstico de nanopoços para diagnóstico de substâncias de doenças cardiovasculares no sangue

Info

Publication number
BR112022018853A2
BR112022018853A2 BR112022018853A BR112022018853A BR112022018853A2 BR 112022018853 A2 BR112022018853 A2 BR 112022018853A2 BR 112022018853 A BR112022018853 A BR 112022018853A BR 112022018853 A BR112022018853 A BR 112022018853A BR 112022018853 A2 BR112022018853 A2 BR 112022018853A2
Authority
BR
Brazil
Prior art keywords
nanowell
blood
cardiovascular disease
diagnostic kit
diagnosis
Prior art date
Application number
BR112022018853A
Other languages
English (en)
Inventor
Yeon Lee Hea
Original Assignee
Mara Nanotech Korea Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200040475A external-priority patent/KR102626879B1/ko
Application filed by Mara Nanotech Korea Inc filed Critical Mara Nanotech Korea Inc
Publication of BR112022018853A2 publication Critical patent/BR112022018853A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5088Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above confining liquids at a location by surface tension, e.g. virtual wells on plates, wires
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3276Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a hybridisation with immobilised receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3277Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a redox reaction, e.g. detection by cyclic voltammetry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3278Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction involving nanosized elements, e.g. nanogaps or nanoparticles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0636Integrated biosensor, microarrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0645Electrodes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0896Nanoscaled
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2223/00Investigating materials by wave or particle radiation
    • G01N2223/30Accessories, mechanical or electrical features
    • G01N2223/301Accessories, mechanical or electrical features portable apparatus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Electrochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Clinical Laboratory Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

KIT DE DIAGNÓSTICO DE NANOPOÇOS PARA DIAGNÓSTICO DE SUBSTÂNCIAS DE DOENÇAS CARDIOVASCULARES NO SANGUE. A presente invenção se refere a um kit de diagnóstico de nanopoços para diagnóstico de uma substância de doença cardiovascular no sangue, incluindo: um eletrodo no qual uma pluralidade de nanopoços é formada para acomodar uma substância alvo; e um marcador fixado a cada um da pluralidade de nanopoços do eletrodo e respondendo à substância alvo, em que a substância alvo é identificada através do método de análise eletroquímica por aplicação de uma corrente ao eletrodo.
BR112022018853A 2020-03-20 2021-03-19 Kit de diagnóstico de nanopoços para diagnóstico de substâncias de doenças cardiovasculares no sangue BR112022018853A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062992167P 2020-03-20 2020-03-20
KR1020200040475A KR102626879B1 (ko) 2020-03-20 2020-04-02 혈중 심혈관 질환 물질 진단을 위한 나노웰 진단키트
PCT/KR2021/003444 WO2021187951A1 (ko) 2020-03-20 2021-03-19 혈중 심혈관 질환 물질 진단을 위한 나노웰 진단키트

Publications (1)

Publication Number Publication Date
BR112022018853A2 true BR112022018853A2 (pt) 2022-11-22

Family

ID=77771491

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022018853A BR112022018853A2 (pt) 2020-03-20 2021-03-19 Kit de diagnóstico de nanopoços para diagnóstico de substâncias de doenças cardiovasculares no sangue

Country Status (6)

Country Link
US (1) US20230126479A1 (pt)
EP (1) EP4123304A4 (pt)
KR (1) KR20240010080A (pt)
CN (1) CN115335702A (pt)
BR (1) BR112022018853A2 (pt)
WO (1) WO2021187951A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4497903B2 (ja) * 2003-12-02 2010-07-07 財団法人大阪産業振興機構 タンパク質チップおよびそれを用いたバイオセンサー
KR101005559B1 (ko) * 2008-07-15 2011-01-05 주식회사 아이센스 바이오센서를 이용한 단백질 측정 장치
KR20150093544A (ko) * 2014-02-07 2015-08-18 한국과학기술연구원 양자점 층을 포함한 비드 입자를 포함하는 복합체 및 이를 이용한 심근경색 관련 질환의 진단 방법
WO2015160085A1 (ko) * 2014-04-14 2015-10-22 부산대학교 산학협력단 전자전달 매개체의 산화환원 순환을 이용한 바이오센서
KR102051811B1 (ko) * 2017-07-27 2019-12-04 고려대학교산학협력단 세포막으로 이루어진 필터를 포함하는 글루코스 측정용 바이오센서
KR102101941B1 (ko) * 2018-03-23 2020-05-29 주식회사 마라나노텍코리아 바이오 센서 제조방법
WO2019183504A1 (en) * 2018-03-23 2019-09-26 Mara Nanotech Korea, Inc. Methods of manufacturing biosensor nanowells
EP3783352A4 (en) * 2018-04-17 2022-01-26 Korea Research Institute of Chemical Technology MULTI-WELL ELECTRODE BASED BIOSENSOR

Also Published As

Publication number Publication date
WO2021187951A1 (ko) 2021-09-23
KR20240010080A (ko) 2024-01-23
EP4123304A1 (en) 2023-01-25
EP4123304A4 (en) 2024-03-20
CN115335702A (zh) 2022-11-11
US20230126479A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
Wurtman Biomarkers in the diagnosis and management of Alzheimer’s disease
Lopez et al. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment
Donadio et al. Skin nerve misfolded α‐synuclein in pure autonomic failure and P arkinson disease
Amminger et al. The NEURAPRO biomarker analysis: long-chain omega-3 fatty acids improve 6-month and 12-month outcomes in youths at ultra-high risk for psychosis
Martins-de-Souza et al. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia
JP2012523009A5 (pt)
BR112018010269A2 (pt) mr-proadm como marcador para o status do volume extracelular de um indivíduo
Cassoli et al. Effect of MK-801 and clozapine on the proteome of cultured human oligodendrocytes
BR112012026219A2 (pt) método diagnósticos para glaucoma
O'Bryant et al. Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
Park et al. Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson’s disease
MA38042A3 (fr) Méthylglyoxal en tant que marqueur du cancer
Lee et al. B-type natriuretic peptide and clinical judgment in the detection of exercise-induced myocardial ischemia
BR112014018204A8 (pt) Método de diagnóstico de distúrbio de células beta pancreáticas em um indivíduo
Biyik et al. Echocardiographic and clinical abnormalities in patients with psoriasis
BR112022018853A2 (pt) Kit de diagnóstico de nanopoços para diagnóstico de substâncias de doenças cardiovasculares no sangue
Mastrobattista et al. Late-life depression is associated with increased levels of GDF-15, a pro-aging mitokine
Naticchioni et al. Transient receptor potential vanilloid 2 regulates myocardial response to exercise
WO2018117064A1 (ja) うつ状態を呈する疾患を検査する方法
CN114980801A (zh) 阿尔茨海默氏病的评价和治疗方法及其应用
BR112022022045A2 (pt) Anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga ao cd103 humano, um ou mais ácidos nucleicos, sistema de expressão, célula hospedeira, composição, métodos de produção de um anticorpo ou fragmento de ligação ao antígeno, para detectar a presença de cd103 em uma amostra biológica, para tratar ou prevenir uma condição mediada por sinalização de cd103 em um indivíduo em necessidade, para inibir a sinalização de cd103 em uma célula, para inibir a ligação de cd103 à e-caderina presente em uma célula, para retirar as células que expressam cd103 em um indivíduo, para tratar ou prevenir uma doença e agente de imageamento
JP6078466B2 (ja) セロトニントランスポーター分析キット及び血中ユビキチン化セロトニントランスポーター分析キット
Yoon et al. Low cocaine-and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients
CA3057013A1 (en) Compositions and methods for diagnosis of peripheral arterial disease
BR112019003408A2 (pt) anticorpo monoclonal contra a melk e utilização da mesma